dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate

C105H138BBr4Cl5K2N26O7 — CID 158539903

IUPACdipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate
SMILESBrc1ccc2cn[nH]c2c1.CN1CCN(CCCn2ncc3ccc(-c4cc(Nc5ccc(Cl)cc5)nc(N5CCOCC5)n4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(B4OC(C)(C)C(C)(C)O4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(Br)cc32)CC1.CN1CCNCC1.ClCCCBr.ClCCCn1ncc2ccc(Br)cc21.Clc1ccc(Nc2cc(Cl)nc(N3CCOCC3)n2)cc1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C29H35ClN8O.C21H33BN4O2.C15H21BrN4.C14H14Cl2N4O.C10H10BrClN2.C7H5BrN2.C5H12N2.C3H6BrCl.CH2O3.2K.H/c1-35-11-13-36(14-12-35)9-2-10-38-27-19-22(3-4-23(27)21-31-38)26-20-28(32-25-7-5-24(30)6-8-25)34-29(33-26)37-15-17-39-18-16-37;1-20(2)21(3,4)28-22(27-20)18-8-7-17-16-23-26(19(17)15-18)10-6-9-25-13-11-24(5)12-14-25;1-18-7-9-19(10-8-18)5-2-6-20-15-11-14(16)4-3-13(15)12-17-20;15-10-1-3-11(4-2-10)17-13-9-12(16)18-14(19-13)20-5-7-21-8-6-20;11-9-3-2-8-7-13-14(5-1-4-12)10(8)6-9;8-6-2-1-5-4-9-10-7(5)3-6;1-7-4-2-6-3-5-7;4-2-1-3-5;2-1-4-3;;;/h3-8,19-21H,2,9-18H2,1H3,(H,32,33,34);7-8,15-16H,6,9-14H2,1-5H3;3-4,11-12H,2,5-10H2,1H3;1-4,9H,5-8H2,(H,17,18,19);2-3,6-7H,1,4-5H2;1-4H,(H,9,10);6H,2-5H2,1H3;1-3H2;1,3H;;;/q;;;;;;;;;2*+1;-1/p-1
InChIKeyIQGCYDRRSIEUTE-UHFFFAOYSA-M
MW2462.32 g/mol
LogP11.98
Rot. Bonds26

About dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate

dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate (PubChem CID 158539903) has the molecular formula C105H138BBr4Cl5K2N26O7 and a molecular weight of 2462.32 g/mol. Its IUPAC name is dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate.

Molecular Properties

Compound Namedipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate
PubChem CID158539903
Molecular FormulaC105H138BBr4Cl5K2N26O7
Molecular Weight2462.32 g/mol
Exact Mass2454.58
IUPAC Namedipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate
SMILESBrc1ccc2cn[nH]c2c1.CN1CCN(CCCn2ncc3ccc(-c4cc(Nc5ccc(Cl)cc5)nc(N5CCOCC5)n4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(B4OC(C)(C)C(C)(C)O4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(Br)cc32)CC1.CN1CCNCC1.ClCCCBr.ClCCCn1ncc2ccc(Br)cc21.Clc1ccc(Nc2cc(Cl)nc(N3CCOCC3)n2)cc1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C29H35ClN8O.C21H33BN4O2.C15H21BrN4.C14H14Cl2N4O.C10H10BrClN2.C7H5BrN2.C5H12N2.C3H6BrCl.CH2O3.2K.H/c1-35-11-13-36(14-12-35)9-2-10-38-27-19-22(3-4-23(27)21-31-38)26-20-28(32-25-7-5-24(30)6-8-25)34-29(33-26)37-15-17-39-18-16-37;1-20(2)21(3,4)28-22(27-20)18-8-7-17-16-23-26(19(17)15-18)10-6-9-25-13-11-24(5)12-14-25;1-18-7-9-19(10-8-18)5-2-6-20-15-11-14(16)4-3-13(15)12-17-20;15-10-1-3-11(4-2-10)17-13-9-12(16)18-14(19-13)20-5-7-21-8-6-20;11-9-3-2-8-7-13-14(5-1-4-12)10(8)6-9;8-6-2-1-5-4-9-10-7(5)3-6;1-7-4-2-6-3-5-7;4-2-1-3-5;2-1-4-3;;;/h3-8,19-21H,2,9-18H2,1H3,(H,32,33,34);7-8,15-16H,6,9-14H2,1-5H3;3-4,11-12H,2,5-10H2,1H3;1-4,9H,5-8H2,(H,17,18,19);2-3,6-7H,1,4-5H2;1-4H,(H,9,10);6H,2-5H2,1H3;1-3H2;1,3H;;;/q;;;;;;;;;2*+1;-1/p-1
InChIKeyIQGCYDRRSIEUTE-UHFFFAOYSA-M
XLogP11.98
TPSA303.05 Ų
H-Bond Donors4
H-Bond Acceptors32
Rotatable Bonds26
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002462.32
LogP ≤ 511.98
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate?
The IUPAC name of dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate (CID 158539903) is dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate.
What is the SMILES notation for dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate?
The canonical SMILES for dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate is Brc1ccc2cn[nH]c2c1.CN1CCN(CCCn2ncc3ccc(-c4cc(Nc5ccc(Cl)cc5)nc(N5CCOCC5)n4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(B4OC(C)(C)C(C)(C)O4)cc32)CC1.CN1CCN(CCCn2ncc3ccc(Br)cc32)CC1.CN1CCNCC1.ClCCCBr.ClCCCn1ncc2ccc(Br)cc21.Clc1ccc(Nc2cc(Cl)nc(N3CCOCC3)n2)cc1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate?
The InChIKey is IQGCYDRRSIEUTE-UHFFFAOYSA-M. The full InChI is InChI=1S/C29H35ClN8O.C21H33BN4O2.C15H21BrN4.C14H14Cl2N4O.C10H10BrClN2.C7H5BrN2.C5H12N2.C3H6BrCl.CH2O3.2K.H/c1-35-11-13-36(14-12-35)9-2-10-38-27-19-22(3-4-23(27)21-31-38)26-20-28(32-25-7-5-24(30)6-8-25)34-29(33-26)37-15-17-39-18-16-37;1-20(2)21(3,4)28-22(27-20)18-8-7-17-16-23-26(19(17)15-18)10-6-9-25-13-11-24(5)12-14-25;1-18-7-9-19(10-8-18)5-2-6-20-15-11-14(16)4-3-13(15)12-17-20;15-10-1-3-11(4-2-10)17-13-9-12(16)18-14(19-13)20-5-7-21-8-6-20;11-9-3-2-8-7-13-14(5-1-4-12)10(8)6-9;8-6-2-1-5-4-9-10-7(5)3-6;1-7-4-2-6-3-5-7;4-2-1-3-5;2-1-4-3;;;/h3-8,19-21H,2,9-18H2,1H3,(H,32,33,34);7-8,15-16H,6,9-14H2,1-5H3;3-4,11-12H,2,5-10H2,1H3;1-4,9H,5-8H2,(H,17,18,19);2-3,6-7H,1,4-5H2;1-4H,(H,9,10);6H,2-5H2,1H3;1-3H2;1,3H;;;/q;;;;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate?
dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate has a molecular weight of 2462.32 g/mol, XLogP of 11.98, 26 rotatable bonds, 4 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-bromo-3-chloropropane;6-bromo-1-(3-chloropropyl)indazole;6-bromo-1H-indazole;6-bromo-1-[3-(4-methylpiperazin-1-yl)propyl]indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-[3-(4-methylpiperazin-1-yl)propyl]indazol-6-yl]-2-morpholin-4-ylpyrimidin-4-amine;hydride;1-methylpiperazine;1-[3-(4-methylpiperazin-1-yl)propyl]-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;oxido formate is sourced from PubChem (CID 158539903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).